Evaluation of biomarkers indicating fibrotic activity in idiopathic pulmonary fibrosis and other diffuse parenchymal lung diseases.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000017

Enrollment

400

Registered

2008-09-05

Start date

2006-03-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J84 J43

Interventions

Group 1: Evaluation of biomarkers after blood sample collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with IPF, COPD, Bronchiolitis obliterans Syndrome, Patients with other ILDs, Healthy Volunteers

Exclusion criteria

Exclusion criteria: known tumor disease known aktive infection

Design outcomes

Primary

Measure	Time frame
Survival, Change in FVC percent predicted (> 10%), Change in TLC percent predicted (> 10%),	—

Secondary

Measure	Time frame
Changes in 6 min shuttle walk test, DLCO.	—

Countries

Germany, Italy

Contacts

Public ContactAntje Prasse

Abteilung für Pneumologie

antje.prasse@uniklinik-freiburg.de0761 2703720

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026